Literature DB >> 27591118

Reversible splenial lesion syndrome in children: Retrospective study and summary of case series.

Wen-Xiong Chen1, Hong-Sheng Liu2, Si-Da Yang3, Si-Hui Zeng2, Yuan-Yuan Gao3, Zhi-Hong Du3, Xiao-Jing Li3, Hai-Sheng Lin3, Hui-Ci Liang3, Jian-Ning Mai3.   

Abstract

OBJECTIVE: To describe clinical features of reversible splenial lesion syndrome (RESLES) in children.
METHODS: Retrospectively analyzed clinical features of RESLES in children and compared differences between severe and non-severe group, classified by clinical global impression-scale; summarized clinical features of children with mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) from case series.
RESULTS: 16 episodes of RESLES occurring in 15 Chinese children were analyzed, with 13 episodes having MERS and 3 episodes with epilepsy. 10 episodes were associated with various pathogens including rotavirus (n=5), adenovirus (n=1), influenza A (n=1), mycoplasma (n=2), and jejunum campylobacter (n=1). The common neurological symptoms included seizure, behavioral changes, altered consciousness and motor deterioration. The lesions of splenium of corpus callosum (SCC), extra-SCC (n=2) or extra-CC (n=1) showed T2-weight and FLAIR hyper-intensity, with the corresponding reduced diffusion. All had complete resolution of radiological changes except 1 episode with small residual. 8 episodes had EEG abnormalities, while elevated white blood count, increased hs-CRP, and hyponatremia were commonly revealed. 7 episodes were given steroid plus therapy, while 3 episodes were treated with antiepileptic drugs. Compared with non-severe group, the number of patients with altered consciousness, EEG abnormalities, motor deterioration, or extra-SCC lesions in severe group was significantly increased. The patients in severe group tended to need longer hospital stay interval. No case caused neurological sequelae, except 1 patient in severe group with recurrent episode and extra-CC lesions having intellectual disability (ID). Five pediatric MERS case series were summarized, including 67 episodes (40 male and 27 female; age ranging 10 m∼13y) from 65 patients, with 33 episodes in Japan, 27 in China, and 7 in Caucasian Australian children, and all patients have a good prognosis except 1 patient with ID (current study).
CONCLUSION: Although RESLES in children tend to be a good outcome, the prognosis of patient in severe group, especially with extra-CC lesions, might have neurological sequelae.
Copyright © 2016 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Case series; Children; Clinical feature; Clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS); Epilepsy; Magnetic resonance image (MRI); Reversible splenial lesion syndrome (RESLES)

Mesh:

Year:  2016        PMID: 27591118     DOI: 10.1016/j.braindev.2016.04.011

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  17 in total

Review 1.  Reversible splenial lesions presenting in conjunction with febrile illness: a case series and literature review.

Authors:  David Lin; Matthew Rheinboldt
Journal:  Emerg Radiol       Date:  2017-05-18

2.  Rotavirus-associated seizures and reversible corpus callosum lesion.

Authors:  Gunta Laizane; Liene Smane; Ieva Nokalna; Dace Gardovska; Kristen A Feemster
Journal:  Acta Med Litu       Date:  2019

3.  Shigella-associated mild encephalitis with reversible splenial lesion in Hospital Center Delafontaine, Saint-Denis, France: a case report.

Authors:  Louise Le Soudéer; Jeanne Truong; Julie Le Gal; Simon Escoda
Journal:  BMC Pediatr       Date:  2022-07-15       Impact factor: 2.567

4.  Mild encephalitis/encephalopathy with a reversible splenial lesion in children.

Authors:  Adalet Elçin Yıldız; Hülya Maraş Genç; Esra Gürkaş; Havva Akmaz Ünlü; İbrahim Halil Öncel; Alev Güven
Journal:  Diagn Interv Radiol       Date:  2018 Mar-Apr       Impact factor: 2.630

5.  COVID-19-Associated Cytotoxic Lesions of the Corpus Callosum.

Authors:  P Gaur; L Dixon; B Jones; H Lyall; W Jan
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-20       Impact factor: 3.825

Review 6.  Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review.

Authors:  Norishi Ueda; Satoshi Minami; Manabu Akimoto
Journal:  BMC Infect Dis       Date:  2016-11-11       Impact factor: 3.090

7.  Reversible splenial lesion syndrome due to oxcarbazepine withdrawal: case report and literature review.

Authors:  Chaoyang Jing; Lichao Sun; Zhuo Wang; Chaojia Chu; Weihong Lin
Journal:  J Int Med Res       Date:  2018-01-11       Impact factor: 1.671

Review 8.  Systematic review of ketogenic diet use in adult patients with status epilepticus.

Authors:  Sherif Hanafy Mahmoud; Ethos Ho-Huang; Jessica Buhler
Journal:  Epilepsia Open       Date:  2019-11-24

9.  Reversible splenial lesion syndrome (RESLES) due to acute intermittent porphyria with a novel mutation in the hydroxymethylbilane synthase gene.

Authors:  Jing Yang; Fei Han; Qianlong Chen; Tienan Zhu; Yongqiang Zhao; Xuezhong Yu; Huadong Zhu; Jian Cao; Xiaoqing Li
Journal:  Orphanet J Rare Dis       Date:  2020-04-19       Impact factor: 4.123

Review 10.  Reversible lesion in the splenium of the corpus callosum.

Authors:  Syuichi Tetsuka
Journal:  Brain Behav       Date:  2019-10-06       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.